CHRONVAC-C Study Followed by Standard of Care in Chronic Hepatitis C Virus (HCV) Subjects
Status:
Unknown status
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
To explore the effect on early viral kinetics and viral load, and to determine safety,
tolerability and anti-viral response for the plasmid DNA vaccine CHRONVAC-C administered i.m.
in combination with electroporation followed by standard of care (SOC) in treatment naïve
chronic HCV genotype 1 patients.